<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Dexmedetomidine for the management of awake fibreoptic intubation - He, X-Y - 2014 | Cochrane Library</title> <meta content="Dexmedetomidine for the management of awake fibreoptic intubation - He, X-Y - 2014 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009798.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Dexmedetomidine for the management of awake fibreoptic intubation - He, X-Y - 2014 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009798.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD009798.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Dexmedetomidine for the management of awake fibreoptic intubation" name="citation_title"/> <meta content="Xing-Ying He" name="citation_author"/> <meta content="Changzheng Hospital, The Second Military Medical University" name="citation_author_institution"/> <meta content="Jian-Ping Cao" name="citation_author"/> <meta content="455 Hospital of the PLA" name="citation_author_institution"/> <meta content="Qian He" name="citation_author"/> <meta content="The Second Military Medical University" name="citation_author_institution"/> <meta content="Xue Y Shi" name="citation_author"/> <meta content="Changzheng Hospital, The Second Military Medical University" name="citation_author_institution"/> <meta content="shixueyin1128@163.com" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="1" name="citation_issue"/> <meta content="10.1002/14651858.CD009798.pub2" name="citation_doi"/> <meta content="2014" name="citation_date"/> <meta content="2014/01/19" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009798.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009798.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009798.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Adrenergic alpha-2 Receptor Agonists; Anti-Anxiety Agents; *Dexmedetomidine; Fentanyl; *Hypnotics and Sedatives; Intubation, Intratracheal [*methods]; Midazolam; Propofol; Randomized Controlled Trials as Topic; *Wakefulness" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009798.pub2&amp;doi=10.1002/14651858.CD009798.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009798.pub2&amp;doi=10.1002/14651858.CD009798.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009798.pub2&amp;doi=10.1002/14651858.CD009798.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009798.pub2&amp;doi=10.1002/14651858.CD009798.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009798.pub2&amp;doi=10.1002/14651858.CD009798.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009798.pub2&amp;doi=10.1002/14651858.CD009798.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009798.pub2&amp;doi=10.1002/14651858.CD009798.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009798.pub2&amp;doi=10.1002/14651858.CD009798.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009798.pub2&amp;doi=10.1002/14651858.CD009798.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009798.pub2&amp;doi=10.1002/14651858.CD009798.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009798.pub2&amp;doi=10.1002/14651858.CD009798.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009798.pub2&amp;doi=10.1002/14651858.CD009798.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009798.pub2&amp;doi=10.1002/14651858.CD009798.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009798.pub2&amp;doi=10.1002/14651858.CD009798.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009798.pub2&amp;doi=10.1002/14651858.CD009798.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009798.pub2&amp;doi=10.1002/14651858.CD009798.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009798.pub2&amp;doi=10.1002/14651858.CD009798.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009798.pub2&amp;doi=10.1002/14651858.CD009798.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009798.pub2&amp;doi=10.1002/14651858.CD009798.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009798.pub2&amp;doi=10.1002/14651858.CD009798.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009798.pub2&amp;doi=10.1002/14651858.CD009798.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009798.pub2&amp;doi=10.1002/14651858.CD009798.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009798.pub2&amp;doi=10.1002/14651858.CD009798.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="ZCrlluee";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009798\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009798\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009798\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009798\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","fa","ms"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD009798.pub2",title:"Dexmedetomidine for the management of awake fibreoptic intubation",firstPublishedDate:"Jan 19, 2014 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Anaesthesia Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=ZCrlluee&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009798.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009798.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD009798.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD009798.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009798.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD009798.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009798.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD009798.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009798.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD009798.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009798.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD009798.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD009798.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009798.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2731 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD009798.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009798.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009798.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009798.pub2/full#CD009798-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009798.pub2/full#CD009798-sec-0076"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009798.pub2/full#CD009798-sec-0008"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009798.pub2/full#CD009798-sec-0013"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009798.pub2/full#CD009798-sec-0014"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009798.pub2/full#CD009798-sec-0043"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009798.pub2/full#CD009798-sec-0069"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009798.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009798.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009798.pub2/appendices#CD009798-sec-0083"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009798.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009798.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009798.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009798.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009798.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009798.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009798.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2014 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD009798.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Dexmedetomidine for the management of awake fibreoptic intubation</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009798.pub2/information#CD009798-cr-0004">Xing-Ying He</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009798.pub2/information#CD009798-cr-0005">Jian-Ping Cao</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009798.pub2/information#CD009798-cr-0006">Qian He</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009798.pub2/information#CD009798-cr-0007"><i class="icon corresponding-author fa fa-envelope"></i>Xue Y Shi</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD009798.pub2/information/en#CD009798-sec-0092">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 19 January 2014 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD009798.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD009798.pub2">https://doi.org/10.1002/14651858.CD009798.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD009798-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009798-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009798-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009798-abs-0005">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009798-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD009798-abs-0001" lang="en"> <section id="CD009798-sec-0001"> <h3 class="title" id="CD009798-sec-0001">Background</h3> <p>Awake fibreoptic intubation (AFOI) frequently requires sedation, anxiolysis and relief of discomfort without impairing ventilation and depressing cardiovascular function. The goal is to allow the patient to be responsive and co‐operative. Medications such as fentanyl, remifentanil, midazolam and propofol have been reported to assist AFOI; however,these agents are associated with cardiovascular or respiratory adverse effects. Dexmedetomidine has been proposed as an alternative to facilitate AFOI. </p> </section> <section id="CD009798-sec-0002"> <h3 class="title" id="CD009798-sec-0002">Objectives</h3> <p>The primary objective of this review is to evaluate and compare the efficacy and safety of dexmedetomidine in the management of patients with a difficult or unstable airway undergoing awake fibreoptic intubation (AFOI). </p> </section> <section id="CD009798-sec-0003"> <h3 class="title" id="CD009798-sec-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL; 2012, Issue 5), MEDLINE (1966 to May 2012) through Ovid, EMBASE (1980 to May 2012) and Web of Science (1945 to May 2012); we screened the reference lists of all eligible trials and reviews to look for further trials and contacted authors of trials to ask for additional information. We searched for ongoing trials at <a href="http://www.controlledtrials.com/" target="_blank">http://www.controlledtrials.com/</a> and http://clinicaltrials.gov/. We reran our search of all databases listed above on 21 November 2013. </p> </section> <section id="CD009798-sec-0004"> <h3 class="title" id="CD009798-sec-0004">Selection criteria</h3> <p>We included published and unpublished randomized controlled trials, regardless of blinding or language of publication, in participants 18 years of age or older who were scheduled for an elective AFOI because of an anticipated difficult airway. Participants received dexmedetomidine or control medications. </p> </section> <section id="CD009798-sec-0005"> <h3 class="title" id="CD009798-sec-0005">Data collection and analysis</h3> <p>Three review authors independently extracted data on study design, participants, interventions and outcomes. We assessed risk of bias using The Cochrane Collaboration’s tool. We estimated risk ratios (RRs) or mean differences (MDs) with 95% confidence internals (CIs) for outcomes with sufficient data; for other outcomes, we performed a qualitative analysis. </p> </section> <section id="CD009798-sec-0006"> <h3 class="title" id="CD009798-sec-0006">Main results</h3> <p>We identified four randomized controlled trials (RCTs), which included 211 participants. The four trials compared dexmedetomidine with midazolam, fentanyl, propofol or a sodium chloride placebo, respectively. The trials showed low or unclear risk of bias primarily because information provided on allocation concealment and other potential sources of bias was inadequate. Owing to clinical heterogeneity and potential methodological heterogeneity, it was impossible to conduct a full meta‐analysis. We described findings from individual studies or presented them in tabular form. Limited evidence was available for assessment of the outcomes of interest for this review. Results of the limited included trials showed that dexmedetomidine significantly reduced participants' discomfort with no significant differences in airway obstruction, low oxygen levels or treatment‐emergent cardiovascular adverse events noted during AFOI compared with control groups. When the search was rerun (from May 2012 to November 2013), it was noted that four studies are awaiting assessment. We will deal with these studies when we update the review. </p> </section> <section id="CD009798-sec-0007"> <h3 class="title" id="CD009798-sec-0007">Authors' conclusions</h3> <p>Small, limited trials provide weak evidence to support dexmedetomidine as an option for patients with an anticipated difficult airway who undergo AFOI. The findings of this review should be further corroborated by additional controlled investigations. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD009798-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009798-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009798-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009798-abs-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ms#CD009798-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009798-abs-0004">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD009798-abs-0002" lang="en"> <h3>Is dexmedetomidine a good option for patients undergoing awake fibreoptic intubation?</h3> <p>This is a review of the clinical evidence from randomized controlled trials on the effect of dexmedetomidine in the management of awake fibreoptic intubation. The review was conducted by researchers in The Cochrane Collaboration. Awake fibreoptic intubation (AFOI) is indicated for the management of patients with a difficult or unstable (critical) airway, such as those with airway deformity or tumour, airway injury or spinal cord instability. It is necessary in such a situation to maintain patient co‐operation and reduce patient anxiety without causing severe adverse effects during the AFOI. Many agents, including fentanyl, remifentanil, midazolam and propofol, have been reported to assist with AFOI. However, these agents can cause respiratory arrest, loss of airway control or reduced cardiovascular (heart) function, especially when used in high doses, thus increasing the risk of low oxygen levels (hypoxaemia), aspiration, low blood pressure (hypotension) or slow heart rate (bradycardia). </p> <p>Dexmedetomidine is a selective alpha‐2‐adrenoceptor agonist that can cause sedation, anxiolysis, analgesic sparing, reduced salivary secretion and minimal respiratory depression; this might be beneficial for patients with a difficult or unstable airway undergoing AFOI. </p> <p>We searched the medical literature until May 2012 and identified four randomized controlled trials involving 211 patients that were appropriate for inclusion in the review. These studies compared dexmedetomidine versus midazolam, fentanyl, propofol or a sodium chloride placebo for patients undergoing AFOI. We reran our search in November 2013, and four studies are awaiting assessment. We will deal with them when we update the review. </p> <p>Dexmedetomidine significantly reduced patient discomfort during AFOI compared with control groups in two included trials. No significant differences in intubation time, airway obstruction, low oxygen levels or treatment‐emergent cardiovascular adverse events were reported during AFOI between the dexmedetomidine group and the control group. </p> <p>Dexmedetomidine did not appear to be inferior to other medications. The data from this evidence database of modest size provide limited evidence to support the use of dexmedetomidine as an alternative or primary choice for AFOI<i>.</i> Further research should focus on this important topic. Additional well‐designed randomized controlled trials are needed to test the exact benefits of dexmedetomidine in the management of AFOI. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD009798-sec-0076" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD009798-sec-0076"></div> <h3 class="title" id="CD009798-sec-0077">Implications for practice</h3> <section id="CD009798-sec-0077"> <section id="CD009798-sec-0078"> <h5 class="title">1. For patients.</h5> <p>In the patient with an at‐risk cervical spine or a difficult airway, it is frequently necessary to maintain patient co‐operation and to reduce anxiety without causing severe adverse effects during AFOI. The pharmacological properties of dexmedetomidine perhaps make it a promising drug in securing the airway and providing better tolerance for patients during AFOI. </p> </section> <section id="CD009798-sec-0079"> <h5 class="title">2. For clinicians.</h5> <p>When performing AFOI, anaesthesiologists may find it difficult to provide enough sedation for patients to be comfortable and co‐operative, while at the same time avoiding airway compromise from excessive sedation. Current clinical data show that dexmedetomidine is an effective alternative for patients with high‐risk airways undergoing AFOI and may provide more comfort and less airway obstruction. Comparable temporary haemodynamic adverse effects were noted in the dexmedetomidine‐treated group when compared with controls (<a href="./references#CD009798-bbs2-0002" title="BergeseSD , CandiottiKA , BokeschPM , ZuraA , WisemandleW , BekkerAY . A Phase IIIb, randomized, double-blind, placebo-controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. American Journal of Therapeutics2010;17(6):586-95. [MEDLINE: 20535016]">Bergese 2010b</a>; <a href="./references#CD009798-bbs2-0003" title="ChuKS , WangFY , HsuHT , LuIC , WangHM , TsaiCJ . The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation. European Journal of Anaesthesiology2010;27(1):36-40. [MEDLINE: 19550337]">Chu 2010</a>; <a href="./references#CD009798-bbs2-0004" title="TsaiCJ , ChuKS , ChenTI , LuDV , WangHM , LuIC . A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation. Anaesthesia2010;65(3):254-9. [MEDLINE: 20105150]">Tsai 2010</a>). </p> </section> <section id="CD009798-sec-0080"> <h5 class="title">3. For policy makers or managers.</h5> <p>Dexmedetomidine might be considered as another option for patients with an anticipated difficult airway undergoing AFOI. </p> </section> </section> <h3 class="title" id="CD009798-sec-0081">Implications for research</h3> <section id="CD009798-sec-0081"> <p>All four included studies mentioned how investigators calculated the sample size. However, studies involving a larger sample size would provide more precise estimates of effects. In addition, the power of this review would have been enhanced by better reporting of data. For example, all included studies did not explicitly state information about "allocation concealment". Overall, the included studies were limited, and additional well‐designed randomized controlled trials are needed to test the exact effects of dexmedetomidine in the management of patients who require awake fibreoptic intubation. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD009798-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD009798-sec-0008"></div> <section id="CD009798-sec-0009"> <h3 class="title" id="CD009798-sec-0009">Description of the condition</h3> <p>Awake fibreoptic intubation (AFOI) is indicated in a variety of clinical situations. An integral part of AFOI is the management of patients with a critical (difficult or unstable) airway, such as airway deformity or tumour, airway injury or spinal cord instability. An ideal situation for AFOI requires sedation, anxiolysis and relief of discomfort without impairing ventilation and depressing cardiovascular function, while allowing the patient to be responsive and co‐operative. Many medications, such as fentanyl, remifentanil, midazolam and propofol, have been reported to assist AFOI (<a href="./references#CD009798-bbs2-0023" title="KnolleE , OehmkeMJ , GustorffB , HellwagnerK , KressHG . Target-controlled infusion of propofol for fibreoptic intubation. European Journal of Anaesthesiology2003;20:565–9. [MEDLINE: 12884991]">Knolle 2003</a>; <a href="./references#CD009798-bbs2-0024" title="LalloA , BillardV , BourgainJL . A comparison of propofol and remifentanil target-controlled infusions to facilitate fiberoptic nasotracheal intubation. Anesthesia and Analgesia2009;108:852-7. [MEDLINE: 19224793]">Lallo 2009</a>; <a href="./references#CD009798-bbs2-0025" title="MachataAM , GonanoC , HolzerA , AndelD , SpissCK , ZimpferM , et al. Awake nasotracheal fiberoptic intubation: patient comfort, intubating conditions, and haemodynamic stability during conscious sedation with remifentanil. Anesthesia and Analgesia2003;97:904–8. [MEDLINE: 12933427]">Machata 2003</a>; <a href="./references#CD009798-bbs2-0027" title="RaiMR , ParryTM , DombrovskisA , WarnerOJ . Remifentanil target-controlled infusion vs propofol target-controlled infusion for conscious sedation for awake fibreoptic intubation: a double-blinded randomized controlled trial. British Journal of Anaesthesia2008;100:125–30. [MEDLINE: 18037667]">Rai 2008</a>). However, these agents can cause respiratory arrest, loss of airway control or cardiovascular depression, especially when used at high doses (<a href="./references#CD009798-bbs2-0013" title="BergeseSD , KhabiriB , RobertsWD , HowieMB , McSweeneyTD , GerhardtMA . Dexmedetomidine for conscious sedation in difficult awake fiberoptic intubation cases. Journal of Clinical Anesthesia2007;19:141-4. [MEDLINE: 17379129]">Bergese 2007</a>; <a href="./references#CD009798-bbs2-0027" title="RaiMR , ParryTM , DombrovskisA , WarnerOJ . Remifentanil target-controlled infusion vs propofol target-controlled infusion for conscious sedation for awake fibreoptic intubation: a double-blinded randomized controlled trial. British Journal of Anaesthesia2008;100:125–30. [MEDLINE: 18037667]">Rai 2008</a>). This increases the risk of hypoxaemia, aspiration, hypotension or bradycardia (<a href="./references#CD009798-bbs2-0012" title="BaileyPL , PaceNL , AshburnMA , MollJW , EastKA , StanleyTH . Frequent hypoxemia and apnea after sedation with midazolam and fentanyl. Anesthesiology1990;73:826-30. [MEDLINE: 2122773]">Bailey 1990</a>). </p> </section> <section id="CD009798-sec-0010"> <h3 class="title" id="CD009798-sec-0010">Description of the intervention</h3> <p>Dexmedetomidine is a selective alpha‐2‐adrenoceptor agonist with properties of sedation, anxiolysis, analgesic sparing and inhibition of salivary secretion (<a href="./references#CD009798-bbs2-0016" title="GerlachAT , DastaJF . Dexmedetomidine:an updated review. The Annals of Pharmacotherapy2007;41:245-54. [MEDLINE: 17299013 ]">Gerlach 2007</a>). The alpha‐2/alpha‐1‐adrenoceptor selectivity ratio is eight‐fold greater than for clonidine, the classic alpha‐2‐adrenoceptor agonist (<a href="./references#CD009798-bbs2-0031" title=" VirtanenR , SavolaJM , SaanoV , NymanL . Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist. European Journal of Pharmacology1988;150:9-14. [MEDLINE: 2900154]">Virtanen 1988</a>). Dexmedetomidine has a half‐life (t<sub>1/2</sub>) of approximately two hours, a duration of action of approximately four hours and a side effect profile that is shorter in duration than that of clonidine (i.e. much shorter influence on normal physiology). </p> <p>When used at higher doses, dexmedetomidine exhibits minimal respiratory depression (<a href="./references#CD009798-bbs2-0015" title="EbertTJ , HallJE , BarneyJA , UhrichTD , ColincoMD . The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology2000;93:382-94. [MEDLINE: 10910487]">Ebert 2000</a>; <a href="./references#CD009798-bbs2-0030" title="VennRM , HellJ , GroundsRM . Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Criticical Care2000;4:302-8. [MEDLINE: 11056756]">Venn 2000</a>). Thus dexmedetomidine has been proposed as a promising drug to use during AFOI for managing patients with a difficult or unstable airway (<a href="./references#CD009798-bbs2-0018" title="HallJE , UhrichTD , BarneyJA , ArainSR , EbertTJ . Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesthesia and Analgesia2000;90:699-705. [MEDLINE: 10702460 ]">Hall 2000</a>; <a href="./references#CD009798-bbs2-0022" title="KamibayashiT , MazeM . Clinical uses of alpha2-adrenergic agonists. Anesthesiology2000;93:1345-9. [PMID: 11046225]">Kamibayashi 2000</a>). Dexmedetomidine has been approved for use in intubated and mechanically ventilated patients in the intensive care unit (ICU), as well as in non‐intubated patients undergoing surgical or other procedures (<a href="./references#CD009798-bbs2-0015" title="EbertTJ , HallJE , BarneyJA , UhrichTD , ColincoMD . The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology2000;93:382-94. [MEDLINE: 10910487]">Ebert 2000</a>). </p> <p>Although dexmedetomidine has beneficial attributes, increasing concentrations of dexmedetomidine in humans results in bradycardia and a biphasic (low, then high) dose‐response relation for mean arterial pressure, especially in patients with intrinsic or drug‐induced bradycardia, hypovolaemia, advanced heart block or severe ventricular dysfunction (<a href="./references#CD009798-bbs2-0015" title="EbertTJ , HallJE , BarneyJA , UhrichTD , ColincoMD . The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology2000;93:382-94. [MEDLINE: 10910487]">Ebert 2000</a>). It is recommended that dexmedetomidine be administered at a loading dose of 1 mcg/kg for at least 10 minutes, followed by a maintenance infusion of 0.2 to 0.5 mcg/kg/h. </p> </section> <section id="CD009798-sec-0011"> <h3 class="title" id="CD009798-sec-0011">How the intervention might work</h3> <p>Dexmedetomidine is pharmacologically unique in that the induced conscious sedation involves activation of the endogenous sleep‐promoting pathway (<a href="./references#CD009798-bbs2-0014" title="CoursinDB , CoursinDB , MaccioliGA . Dexmedetomidine. Current Opinion in Critical Care2001;7:221-6. [MEDLINE: 11571417]">Coursin 2001</a>). Dexmedetomidine could provide sedation and anxiolysis via receptors within the locus coeruleus, which is an important modulator of wakefulness. Meanwhile, dexmedetomidine could provide analgesic sparing via receptors in the spinal cord and attenuation of the stress response with no significant respiratory depression (<a href="./references#CD009798-bbs2-0016" title="GerlachAT , DastaJF . Dexmedetomidine:an updated review. The Annals of Pharmacotherapy2007;41:245-54. [MEDLINE: 17299013 ]">Gerlach 2007</a>). </p> <p>As an alpha‐2‐adrenoceptor agonist, dexmedetomidine when infused may lead to short‐loop feedback inhibition of adrenaline (epinephrine) release from the adrenal gland. The clinical significance of this has yet to be determined. </p> </section> <section id="CD009798-sec-0012"> <h3 class="title" id="CD009798-sec-0012">Why it is important to do this review</h3> <p>The properties of dexmedetomidine may be beneficial for patients with a difficult or unstable airway undergoing AFOI when used as a sole infusion or as an adjuvant (<a href="./references#CD009798-bbs2-0011" title="AbdelmalakB , MakaryL , HobanJ , DoyleDJ . Dexmedetomidine as sole sedative for awake intubation in management of the critical airway. Journal of Clinical Anesthesia2007;19:370-3. [MEDLINE: 17869990]">Abdelmalak 2007</a>; <a href="./references#CD009798-bbs2-0026" title="MaroofM , KhanRM , JainD , AshrafM . Dexmedetomidine is a useful adjunct for awake intubation. Canadian Journal of Anaesthesia2005;52:776–7. [MEDLINE: 16103401 ]">Maroof 2005</a>). Case reports and studies have demonstrated the successful use of dexmedetomidine in AFOI (<a href="./references#CD009798-bbs2-0013" title="BergeseSD , KhabiriB , RobertsWD , HowieMB , McSweeneyTD , GerhardtMA . Dexmedetomidine for conscious sedation in difficult awake fiberoptic intubation cases. Journal of Clinical Anesthesia2007;19:141-4. [MEDLINE: 17379129]">Bergese 2007</a>; <a href="./references#CD009798-bbs2-0017" title="GrantSA , BreslinDS , MacLeodDB , GleasonD , MartinG . Dexmedetomidine infusion for sedation during fiberoptic intubation:a report of three cases. Journal of Clinical Anesthesia2004;16:124-6. [MEDLINE: 15110375]">Grant 2004</a>; <a href="./references#CD009798-bbs2-0020" title=" JoosteEH , OhkawaS , SunLS . Fiberoptic intubation with dexmedetomidine in two children with spinal cord impingements. Anesthesia and Analgesia2005;101:1248. [MEDLINE: 16192567 ]">Jooste 2005</a>). On the other hand, dexmedetomidine has sympathetic modulating properties, which may be responsible for potential haemodynamic side effects, such as bradycardia, hypotension or conduction block, particularly in those who are hypovolaemic or bleeding or who have cardiac conduction or cardiac contractility limitations. It is important to perform a systematic review to assess the effectiveness of dexmedetomidine during AFOI and to document possible adverse effects or complications. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD009798-sec-0013" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD009798-sec-0013"></div> <p>The primary objective of this review is to evaluate and compare the efficacy and safety of dexmedetomidine in the management of patients with a difficult or unstable airway undergoing awake fibreoptic intubation (AFOI). </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD009798-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD009798-sec-0014"></div> <section id="CD009798-sec-0015"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD009798-sec-0016"> <h4 class="title">Types of studies</h4> <p>We included published and unpublished randomized controlled trials, regardless of blinding or language of publication. </p> </section> <section id="CD009798-sec-0017"> <h4 class="title">Types of participants</h4> <p>We included any patient older than 18 years of age who was scheduled for an elective AFOI because of an anticipated difficult airway. </p> </section> <section id="CD009798-sec-0018"> <h4 class="title">Types of interventions</h4> <p>Dexmedetomidine versus any other control.</p> </section> <section id="CD009798-sec-0019"> <h4 class="title">Types of outcome measures</h4> <section id="CD009798-sec-0020"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD009798-list-0001"> <li> <p>Discomfort during AFOI (heavy grimacing, verbal objection, defensive movement of head or hand or prolonged cough). </p> </li> </ol> </p> </section> <section id="CD009798-sec-0021"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD009798-list-0002"> <li> <p>Intubation time.</p> </li> <li> <p>Airway obstruction (requiring neck extension or jaw retraction).</p> </li> <li> <p>Hypoxia (saturated peripheral oxygen (SpO<sub>2</sub>) &lt; 90%). </p> </li> <li> <p>Treatment‐emergent cardiovascular adverse events, mainly hypotension and bradycardia.</p> </li> </ol> </p> </section> </section> </section> <section id="CD009798-sec-0022"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD009798-sec-0023"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL; 2012, issue 5) using the search terms detailed in <a href="./appendices#CD009798-sec-0084">Appendix 1</a> MEDLINE (1966 to May 2012) through Ovid; EMBASE (1980 to May 2012); and Web of Science (1945 to May 2012), using a similar strategy. (The search strategies will be found in <a href="./appendices#CD009798-sec-0085">Appendix 2</a><a href="./appendices#CD009798-sec-0086">Appendix 3</a> and <a href="./appendices#CD009798-sec-0087">Appendix 4</a>.) We combined the sensitive strategies described in Section 6.4 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009798-bbs2-0019" title="Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.">Higgins 2011</a>) to search for randomized controlled trials (RCTs) in MEDLINE and EMBASE. We used the free text and associated exploded MeSH terms in combination with the RCT sensitive search strategy detailed in <a href="./appendices#CD009798-sec-0088">Appendix 5</a>. We incorporated any identified new terms into the search strategy. We reported the modified search strategy in full in the final review. </p> <p>We reran our search of all databases described above on 21 November 2013.</p> <p>We applied no language restrictions.</p> </section> <section id="CD009798-sec-0024"> <h4 class="title">Searching other resources</h4> <p>We screened the reference lists of all eligible trials and reviews.</p> <p>We contacted experts to identify unpublished research and trials still under way. We searched for ongoing trials at <a href="http://www.controlledtrials.com/" target="_blank">http://www.controlledtrials.com/</a> and http://clinicaltrials.gov/ . </p> </section> </section> <section id="CD009798-sec-0025"> <h3 class="title" id="CD009798-sec-0025">Data collection and analysis</h3> <section id="CD009798-sec-0026"> <h4 class="title">Selection of studies</h4> <p>Using results of the above searches, we screened all titles and abstracts for eligibility. Two review authors (X‐YH and J‐PC) independently performed this screening. Each review author documented the reason for exclusion of each trial. We resolved disagreements by consulting with a third review author (X‐YS), who decided on inclusion. In the case of insufficient published information available for decision making about inclusion, we contacted the first author of the relevant trial. </p> </section> <section id="CD009798-sec-0027"> <h4 class="title">Data extraction and management</h4> <section id="CD009798-sec-0028"> <h5 class="title">1. Extraction.</h5> <p>Two review authors (X‐YH and J‐PC) independently screened the titles and abstracts of search results for trial eligibility. We extracted and collected on a paper form the data from any trial that met our inclusion criteria. We noted the reasons for exclusions. We resolved disagreements by consulting with a third review author (X‐YS), who decided on inclusion. If further information was required from the trial authors, X‐YH would contact the first author of the relevant trial. </p> </section> <section id="CD009798-sec-0029"> <h5 class="title">2. Management.</h5> <section id="CD009798-sec-0030"> <h6 class="title">2.1 Conversion of ordinal to dichotomous outcome measures.</h6> <p>We converted ordinal outcome measures to dichotomous outcome measures by identifying cut‐off points on rating scales and dividing participants accordingly into 'clinically significant response' or 'no clinically significant response'. It was generally assumed that if participants displayed heavy grimacing, verbal objection, defensive movement of head or hand or prolonged cough, this could be considered as clinically significant discomfort. Similarly, if participants required neck extension or jaw retraction, this could be considered a case of clinically significant airway obstruction. </p> </section> </section> </section> <section id="CD009798-sec-0031"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (X‐YH and J‐PC) independently assessed the methodological quality of eligible trials. We resolved disagreements by discussion with a third review author (X‐YS). </p> <p>We performed the assessment as suggested in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009798-bbs2-0019" title="Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.">Higgins 2011</a>) and by Juni (<a href="./references#CD009798-bbs2-0021" title="JuniP , AltmanD , EggerM . Systematic reviews in health care:assessing the quality of controlled clinical trials. BMJ2001;323(7303):42-6. [MEDLINE: 11440947 ]">Juni 2001</a>). </p> <p>We considered a trial as having a low risk of bias if all of the following criteria were assessed as adequate. We considered a trial as having a high risk of bias if one or more of the following criteria were not assessed as adequate. </p> <p>We assessed each trial according to the following quality domains.</p> <p> <ol id="CD009798-list-0003"> <li> <p>Random sequence generation: We considered allocation adequate if it was generated by a computer or by a random number table algorithm. We judged other processes as adequate, such as tossing of a coin, if the whole sequence was generated before the start of the trial, and if it was performed by a person not otherwise involved in participant recruitment. We considered allocation inadequate if a non‐random system such as dates, names or identification numbers was used. </p> </li> <li> <p>Allocation concealment: We considered concealment adequate if the process used prevented participant recruiters, investigators and participants from knowing the intervention allocation of the next participant to be enrolled in the study. Acceptable systems included a central allocation system, sealed opaque envelopes and an on‐site locked computer. We considered concealment inadequate if the allocation method that was used allowed participant recruiters, investigators or participants to know the treatment allocation of the next participant to be enrolled in the study (e.g. alternate medical record numbers, reference to case record numbers or date of birth, an open allocation sequence, unsealed envelopes). </p> </li> <li> <p>Blinding: We considered blinding adequate if participants and outcome assessors were each blinded to the intervention. We considered blinding inadequate if participants and outcome assessors were not blinded to the intervention. </p> </li> <li> <p>Intention‐to‐treat: We considered intention‐to‐treat (ITT) adequate if all dropouts or withdrawals were accounted for. We considered ITT inadequate if the number of dropouts or withdrawals was not stated, or if the reasons for dropouts or withdrawals were not stated. </p> </li> </ol> </p> <p>We reported the 'Risk of bias' table as part of the table <a href="./references#CD009798-sec-0099" title="">Characteristics of included studies</a> and presented 'Risk of bias summary' figures (<a href="#CD009798-fig-0001">Figure 1</a><a href="#CD009798-fig-0002">Figure 2</a>, which detailed all judgements made for all studies included in the review. </p> <div class="figure" id="CD009798-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD009798-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009798.pub2/media/CDSR/CD009798/image_n/nCD009798-FIG-01.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD009798-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study." data-id="CD009798-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009798.pub2/media/CDSR/CD009798/image_n/nCD009798-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> </div> </section> <section id="CD009798-sec-0032"> <h4 class="title">Measures of treatment effect</h4> <p>We presented dichotomous data as risk ratios. We presented numerical comparisons as differences between means. </p> </section> <section id="CD009798-sec-0033"> <h4 class="title">Unit of analysis issues</h4> <p>The following were addressed: studies with multiple treatment groups. We combined all relevant experimental intervention groups of the study into a single group, and we combined all relevant control intervention groups into a single control group. </p> </section> <section id="CD009798-sec-0034"> <h4 class="title">Dealing with missing data</h4> <p>We contacted the first author of included trials to try to obtain missing data. In the case of missing data, we used best case and worst case imputation of missing data. We ignored data that were missing at random, and we dealt with missing data not at random by using imputed data or statistical models. </p> </section> <section id="CD009798-sec-0035"> <h4 class="title">Assessment of heterogeneity</h4> <section id="CD009798-sec-0036"> <h5 class="title">1. Clinical heterogeneity.</h5> <p>We considered all included studies before determining clinical heterogeneity. We inspected all studies for outlying clinical situations or participants. When such situations or participant groups arose, we discussed them. </p> </section> <section id="CD009798-sec-0037"> <h5 class="title">2. Methodological heterogeneity.</h5> <p>We considered all included studies initially before determining methodological heterogeneity. We inspected all studies for outlying methods. When methodological outliers arose, we discussed them clearly. </p> </section> <section id="CD009798-sec-0038"> <h5 class="title">3. Statistical heterogeneity.</h5> <p>We assessed statistical heterogeneity with the I<sup>2</sup> statistic, thereby estimating the percentage of total variance across studies that was due to heterogeneity rather than to chance alone (<a href="./references#CD009798-bbs2-0019" title="Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.">Higgins 2011</a>). The importance of the observed value of I<sup>2</sup> depended on: </p> <p> <ol id="CD009798-list-0004"> <li> <p>magnitude and direction of effects; and</p> </li> <li> <p>strength of evidence for heterogeneity (e.g. P value from the Chi<sup>2</sup> test, or confidence interval (CI) for I<sup>2</sup>). </p> </li> </ol> </p> <p>We considered a value of I<sup>2</sup> greater than or equal to 50% accompanied by a statistically significant I<sup>2</sup> statistic as evidence of substantial levels of heterogeneity, although we acknowledged that values of I<sup>2</sup> ranging from 30% to 60% might also indicate substantial heterogeneity. When we found substantial levels of heterogeneity, we explored reasons for the heterogeneity. If strong heterogeneity was present (I<sup>2</sup> ≥ 75%) and could not be explained by differences across trials in terms of clinical or methodological features, or by subgroup analyses, we did not combine the trials in a meta‐analysis, but we presented the results in a forest plot. </p> </section> </section> <section id="CD009798-sec-0039"> <h4 class="title">Assessment of reporting biases</h4> <p>If more than 10 studies were included, we planned to assess publication bias and small‐study effects in a qualitative manner, using a funnel plot. We planned to use arcsine asymmetry tests that stabilized the variance of binary outcomes (<a href="./references#CD009798-bbs2-0029" title="RucherG , SchwarzerG , GarpenterJ . Arcsine test for publication bias in meta-analyses with binary outcomes. Statistics in Medicine2008;27(5):746-63. [MEDLINE: 17592831]">Rucker 2008</a>). </p> </section> <section id="CD009798-sec-0040"> <h4 class="title">Data synthesis</h4> <p>We intended to analyse data by using Review Manager software (<a href="./references#CD009798-bbs2-0028" title="The Nordic Cochrane Centre, The Cochrane CollaborationReview Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.">RevMan 5.1</a>) with a Mantel‐Haenzsel fixed‐effect model. This approach was intended to minimize the impact of small studies on the primary analysis of data, while addressing the issue of small‐study effects. However, we were unable to implement these methods, as the appropriate data were not available in the included studies. </p> </section> <section id="CD009798-sec-0041"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We performed no subgroup analyses.</p> </section> <section id="CD009798-sec-0042"> <h4 class="title">Sensitivity analysis</h4> <p>We performed sensitivity analyses of trials with a low risk of bias versus a high risk of bias. We compared random‐effects model and fixed‐effect model estimates for each outcome variable. We excluded and included any study that appeared to have a large effect size (often the largest or earliest study) to assess its impact on the results of the meta‐analysis. If large variations in the control group event rate were noted, we also subjected trials with different rates to sensitivity analysis. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD009798-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD009798-sec-0043"></div> <section id="CD009798-sec-0044"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#CD009798-sec-0099" title="">Characteristics of included studies</a>; <a href="./references#CD009798-sec-0100" title="">Characteristics of excluded studies</a>; and <a href="./references#CD009798-sec-0101" title="">Characteristics of studies awaiting classification</a>. </p> <section id="CD009798-sec-0045"> <h4 class="title">Results of the search</h4> <p>We identified six potentially eligible studies following screening of abstracts of potential studies. We found no ongoing trials and no trials awaiting assessment. The two review authors (X‐YH and J‐PC) completely agreed on the selection of included studies. We obtained no additional information from the primary authors. We reran our search on 21 November 2013, and four studies are awaiting assessment (<a href="./references#CD009798-bbs2-0007" title="CattanoD , LamNC , FerrarioL , SeitanC , VahdatK , WilcoxDW , et al. Dexmedetomidine versus remifentanil for sedation during awake fiberoptic intubation. Anesthesiology Research and Practice [electronic resource]2012;Epub Jul 16. [MEDLINE: 22844277]">Cattano 2012</a>; <a href="./references#CD009798-bbs2-0008" title="HuR , LiuJX , JiangH . Dexmedetomidine versus remifentanil sedation during awake fiberoptic nasotracheal intubation:a double-blinded randomized controlled trial. Journal of Anesthesia2013;27:211-7. [MEDLINE: 23073729]">Hu 2013</a>; <a href="./references#CD009798-bbs2-0009" title="LiXB , LiuHQ , MengXY , YuanT , HanW , TongT , et al. Application of dexmedetomidine combined with fibreoptic bronchoscope for tracheal intubation in difficult airways caused by huge goiter. Journal of Jilin Universtiy (Medical Edition)2012;38:328-32. ">Li 2012</a>; <a href="./references#CD009798-bbs2-0010" title="QiuL , ZhangL , JiJ . Sedation effect of dexmedetomidine on awake intubation in patients with difficult airway. Pharmaceutical Care and Research2013;13:208-12. ">Qiu 2013</a>). We will deal with these studies when we update the review. </p> </section> <section id="CD009798-sec-0046"> <h4 class="title">Included studies</h4> <p>We included in this review four studies (<a href="./references#CD009798-bbs2-0001" title="BergeseSD , Patrick BenderS , McSweeneyTD , FernandezS , DzwonczykR , SageK . A comparative study of dexmedetomidine with midazolam and midazolam alone for sedation during elective awake fiberoptic intubation. Journal of Clinical Anesthsia2010;22(1):35-40. [MEDLINE: 20206849]">Bergese 2010a</a>; <a href="./references#CD009798-bbs2-0002" title="BergeseSD , CandiottiKA , BokeschPM , ZuraA , WisemandleW , BekkerAY . A Phase IIIb, randomized, double-blind, placebo-controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. American Journal of Therapeutics2010;17(6):586-95. [MEDLINE: 20535016]">Bergese 2010b</a>; <a href="./references#CD009798-bbs2-0003" title="ChuKS , WangFY , HsuHT , LuIC , WangHM , TsaiCJ . The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation. European Journal of Anaesthesiology2010;27(1):36-40. [MEDLINE: 19550337]">Chu 2010</a>; <a href="./references#CD009798-bbs2-0004" title="TsaiCJ , ChuKS , ChenTI , LuDV , WangHM , LuIC . A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation. Anaesthesia2010;65(3):254-9. [MEDLINE: 20105150]">Tsai 2010</a>) published between 2010 and May 2012. See <a href="#CD009798-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD009798-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD009798-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009798.pub2/media/CDSR/CD009798/image_n/nCD009798-FIG-03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <section id="CD009798-sec-0047"> <h5 class="title">1. Methods.</h5> <p>All studies were started to be randomized and double‐blinded. For further details, please see sections below on <a href="#CD009798-sec-0056">Allocation (selection bias)</a> and <a href="#CD009798-sec-0057">Blinding (performance bias and detection bias)</a>. </p> </section> <section id="CD009798-sec-0048"> <h5 class="title">2. Design.</h5> <p>All studies were randomized control trials and presented a parallel longitudinal design.</p> <p><a href="./references#CD009798-bbs2-0001" title="BergeseSD , Patrick BenderS , McSweeneyTD , FernandezS , DzwonczykR , SageK . A comparative study of dexmedetomidine with midazolam and midazolam alone for sedation during elective awake fiberoptic intubation. Journal of Clinical Anesthsia2010;22(1):35-40. [MEDLINE: 20206849]">Bergese 2010a</a> This was a double‐blinded (participant and assessor), randomized comparison study. Participants were randomly assigned (by computer‐generated randomization schedule) to the midazolam (MDZ) group (n = 24) or the dexmedetomidine‐midazolam (DEX‐MDZ) group (n = 31) 15 minutes before fibreoptic intubation. MDZ participants received IV midazolam 0.05 mg/kg with additional doses at 0.05 mg/kg until their Ramsay Sedation Score (RSS) was ≥ 2. DEX‐MDZ participants received midazolam 0.02 mg/kg followed by dexmedetomidine 1 μg/kg bolus infusion over 15 minutes. DEX‐MDZ participants then received dexmedetomidine 0.1 to 0.7 μg/kg/h infusion until their RSS was ≥ 2. Topical local anaesthesia was performed with 2% lidocaine solution followed by a 4‐mL injection of lidocaine 4% transtracheally. One of two trained, independent, study‐blinded observers assessed participant reaction to the fibreoptic intubation on a scale of one to five (one = no reaction; two = slight grimacing; three = severe grimacing; four = verbal objection; and five = defensive movement of head, hands or feet). </p> <p>Ramsay Sedation Scale (RSS: one to six): one: Participant is anxious and agitated or restless, or both; two: Participant is co‐operative, oriented and tranquil; three: Participant responds to command only; four: Participant exhibits brisk response to light glabellar (between the eyebrows) tap or loud auditory stimulus; five: Participant exhibits a sluggish response to light glabellar tap or loud auditory stimulus; six: Participant exhibits no response to stimulus. </p> <p><a href="./references#CD009798-bbs2-0002" title="BergeseSD , CandiottiKA , BokeschPM , ZuraA , WisemandleW , BekkerAY . A Phase IIIb, randomized, double-blind, placebo-controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. American Journal of Therapeutics2010;17(6):586-95. [MEDLINE: 20535016]">Bergese 2010b</a> This was a prospective, randomized, double‐blind, placebo‐controlled study. The study drug was started 15 minutes before airway topicalization for AFOI and was continued through intubation. Dexmedetomidine participants (n = 47) received a loading dose of 1.0 mcg/kg over 10 minutes followed by a continuous infusion of 0.7 mcg/kg<sup>‐1</sup>/h<sup>‐1</sup>. Placebo participants (n = 39) received a loading dose and a maintenance infusion of 0.9% sodium chloride for injection at a volume and rate equal to that of dexmedetomidine. Fifteen minutes after the start of the study drug infusion and before airway topicalization, the participant's level of sedation was assessed using the RSS. Any participant rated as &lt; two on this scale was given rescue midazolam in 0.5‐mg bolus doses until RSS ≥ two was attained. Airway anaesthesia was achieved using lidocaine via aerosol, spray, topical jelly, gargle and/or nerve blocks. Study drug infusion was stopped upon completion of the AFOI. All adverse effects and concomitant medications were recorded. </p> <p><a href="./references#CD009798-bbs2-0003" title="ChuKS , WangFY , HsuHT , LuIC , WangHM , TsaiCJ . The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation. European Journal of Anaesthesiology2010;27(1):36-40. [MEDLINE: 19550337]">Chu 2010</a>: This was a randomized controlled study. Participants in the Dex group (n = 16) received dexmedetomidine infusion, while the control group (n = 14) received fentanyl infusion. Each participant was given a loading dose of dexmedetomidine (1.0 μg/kg<sup>‐1</sup>) or fentanyl (1.0 μg/kg‐<sup>1</sup>) for 10 minutes. After the middle of infusion, topical anaesthesia was performed: Bilateral inferior nasal canals were packed with 6% cocaine (60 mg), and the tongue and the hypopharynx were then sprayed with 10% lidocaine (60 mg). Two experienced consultant anaesthetists performed airway management. While one consultant performed AFOI, another consultant controlled the drug infusion and recorded anaesthetic data. Immediately at the end of study drug infusion, the consultant started to perform fibreoptic scope. The consultant who performed AFOI, the participants and the postoperative recorder were blinded to each participant's group. Main outcomes measures were nasal intubation score (one: no movement; two: grimacing; three: mild cough; four: major limb movement; five: prolonged cough). Secondary outcomes included consumption time from insertion of fibreoptic scope to confirmation of nasal tracheal intubation, hypoxic episode (SpO<sub>2</sub> &lt; 95%) and the use of atropine or ephedrine for haemodynamic support. </p> <p><a href="./references#CD009798-bbs2-0004" title="TsaiCJ , ChuKS , ChenTI , LuDV , WangHM , LuIC . A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation. Anaesthesia2010;65(3):254-9. [MEDLINE: 20105150]">Tsai 2010</a>: This was a randomized controlled study. Participants in the Dex group (n = 20) received a loading dose of dexmedetomidine (1.0 μg/kg<sup>‐1</sup>) infused over 10 minutes. Participants in the propofol group (n = 20) received propofol administered by a Primea TCI pump (Fresenius Kabi, Brezins, France). The initial target effect site concentration (Ce) was set at 3 μg/mL<sup>‐1</sup> and was adjusted by 1.0 μg/mL<sup>‐1</sup> according to participant comfort during the procedure. While waiting for the desired level of sedation to be achieved, topical anaesthesia was applied to the airway. Cocaine 6% (60 mg) packs were applied bilaterally to the inferior nasal canals; then, the tongue and the hypopharynx were sprayed with lidocaine 10% (60 mg). Fibreoptic intubation was performed once the dexmedetomidine infusion had ended, or when the propofol infusion target concentration at the effect site (Ce) had equilibrated with the plasma concentration (Cp). Two experienced consultant anaesthetists performed airway management. While one anaesthetist performed fibreoptic intubation, the other anaesthetist controlled the drug infusion. Anaesthetic data and postoperative visits were documented by a study nurse. The intubating anaesthetist, participants and the study nurse who recorded details of the procedures were all blinded to the study. The primary outcome measurements were participant tolerance, as assessed by a five‐point fibreoptic intubation comfort score (one: no reaction; two: slight grimacing; three: heavy grimacing; four: verbal objection; five: defensive movement of head or hands). Other parameters assessed in relation to awake fibreoptic intubation included an airway obstruction score (one: patent airway; two: airway obstruction relieved by neck extension; three: airway obstruction requiring jaw retraction); intubation time (time from insertion of the fibreoptic scope to confirmation of nasotracheal intubation); any hypoxic episode (SpO<sub>2</sub> &lt; 90%); and the need for atropine or adrenaline administration.  </p> </section> <section id="CD009798-sec-0049"> <h5 class="title">3. Duration.</h5> <p>Three studies (<a href="./references#CD009798-bbs2-0001" title="BergeseSD , Patrick BenderS , McSweeneyTD , FernandezS , DzwonczykR , SageK . A comparative study of dexmedetomidine with midazolam and midazolam alone for sedation during elective awake fiberoptic intubation. Journal of Clinical Anesthsia2010;22(1):35-40. [MEDLINE: 20206849]">Bergese 2010a</a>; <a href="./references#CD009798-bbs2-0003" title="ChuKS , WangFY , HsuHT , LuIC , WangHM , TsaiCJ . The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation. European Journal of Anaesthesiology2010;27(1):36-40. [MEDLINE: 19550337]">Chu 2010</a>; <a href="./references#CD009798-bbs2-0004" title="TsaiCJ , ChuKS , ChenTI , LuDV , WangHM , LuIC . A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation. Anaesthesia2010;65(3):254-9. [MEDLINE: 20105150]">Tsai 2010</a>) were of short duration (less than two days), but one (<a href="./references#CD009798-bbs2-0002" title="BergeseSD , CandiottiKA , BokeschPM , ZuraA , WisemandleW , BekkerAY . A Phase IIIb, randomized, double-blind, placebo-controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. American Journal of Therapeutics2010;17(6):586-95. [MEDLINE: 20535016]">Bergese 2010b</a>) had a follow‐up period of 30 days. </p> </section> <section id="CD009798-sec-0050"> <h5 class="title">4. Participants.</h5> <p>The total number of included participants was 211. All participants were 18 years of age and older and were scheduled for an elective AFOI because of an anticipated difficult airway. </p> </section> <section id="CD009798-sec-0051"> <h5 class="title">5. Setting.</h5> <p>All studies were conducted in a hospital setting. Two studies (<a href="./references#CD009798-bbs2-0001" title="BergeseSD , Patrick BenderS , McSweeneyTD , FernandezS , DzwonczykR , SageK . A comparative study of dexmedetomidine with midazolam and midazolam alone for sedation during elective awake fiberoptic intubation. Journal of Clinical Anesthsia2010;22(1):35-40. [MEDLINE: 20206849]">Bergese 2010a</a>; <a href="./references#CD009798-bbs2-0002" title="BergeseSD , CandiottiKA , BokeschPM , ZuraA , WisemandleW , BekkerAY . A Phase IIIb, randomized, double-blind, placebo-controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. American Journal of Therapeutics2010;17(6):586-95. [MEDLINE: 20535016]">Bergese 2010b</a>) were conducted in the USA, and the remaining two studies (<a href="./references#CD009798-bbs2-0003" title="ChuKS , WangFY , HsuHT , LuIC , WangHM , TsaiCJ . The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation. European Journal of Anaesthesiology2010;27(1):36-40. [MEDLINE: 19550337]">Chu 2010</a>; <a href="./references#CD009798-bbs2-0004" title="TsaiCJ , ChuKS , ChenTI , LuDV , WangHM , LuIC . A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation. Anaesthesia2010;65(3):254-9. [MEDLINE: 20105150]">Tsai 2010</a>) were conducted in Taiwan. </p> </section> <section id="CD009798-sec-0052"> <h5 class="title">6. Interventions.</h5> <p>Dexmedetomidine was compared with no treatment in one study (<a href="./references#CD009798-bbs2-0002" title="BergeseSD , CandiottiKA , BokeschPM , ZuraA , WisemandleW , BekkerAY . A Phase IIIb, randomized, double-blind, placebo-controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. American Journal of Therapeutics2010;17(6):586-95. [MEDLINE: 20535016]">Bergese 2010b</a>), with propofol in one study (<a href="./references#CD009798-bbs2-0004" title="TsaiCJ , ChuKS , ChenTI , LuDV , WangHM , LuIC . A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation. Anaesthesia2010;65(3):254-9. [MEDLINE: 20105150]">Tsai 2010</a>) and with fentanyl in one study (<a href="./references#CD009798-bbs2-0003" title="ChuKS , WangFY , HsuHT , LuIC , WangHM , TsaiCJ . The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation. European Journal of Anaesthesiology2010;27(1):36-40. [MEDLINE: 19550337]">Chu 2010</a>). In addition, dexmedetomidine with midazolam was compared with midazolam only in one study (<a href="./references#CD009798-bbs2-0001" title="BergeseSD , Patrick BenderS , McSweeneyTD , FernandezS , DzwonczykR , SageK . A comparative study of dexmedetomidine with midazolam and midazolam alone for sedation during elective awake fiberoptic intubation. Journal of Clinical Anesthsia2010;22(1):35-40. [MEDLINE: 20206849]">Bergese 2010a</a>). </p> </section> <section id="CD009798-sec-0053"> <h5 class="title">7.Outcomes.</h5> <p>The primary outcome "Discomfort during awake fibreoptic intubation" was not presented in raw data in two studies (<a href="./references#CD009798-bbs2-0003" title="ChuKS , WangFY , HsuHT , LuIC , WangHM , TsaiCJ . The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation. European Journal of Anaesthesiology2010;27(1):36-40. [MEDLINE: 19550337]">Chu 2010</a>; <a href="./references#CD009798-bbs2-0004" title="TsaiCJ , ChuKS , ChenTI , LuDV , WangHM , LuIC . A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation. Anaesthesia2010;65(3):254-9. [MEDLINE: 20105150]">Tsai 2010</a>); this made it impossible to extract data for synthesis, so we contacted the first author of the relevant study and obtained details of the raw data (<a href="#CD009798-tbl-0001">Table 1</a>; <a href="#CD009798-tbl-0002">Table 2</a>). Other outcomes were expressed by numerical data or ordinal data. </p> <div class="table" id="CD009798-tbl-0001"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Raw data for Chu 2010</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FOI comfort (1, 2, 3, 4, 5)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Dexmedetomidine</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Fentanyl</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD009798-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Raw data for Tsai 2010</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FOI comfort (1, 2, 3, 4, 5)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Dexmedetomidine</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Propofo</b>l </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> </tr> </tbody> </table> </div> </section> </section> <section id="CD009798-sec-0054"> <h4 class="title">Excluded studies</h4> <p>The review excluded two studies published between 2010 and 2012 (<a href="./references#CD009798-bbs2-0005" title="BoydBC , SutterSJ . Dexmedetomidine sedation for awake fiberoptic intubation of patients with difficult airways due to severe odontogenic cervicofacial infections. Journal of Oral and Maxillofacial Surgery2011;69:1608-12. [MEDLINE: 21392875]">Boyd 2011</a>; <a href="./references#CD009798-bbs2-0006" title="SwanikerJ , GlickD . The impact of adjunct dexmedetomidine use on opioid requirements and hemodynamic stability during awake fiberoptic intubation. 2011 Annual Meeting of the International Anesthesia Research Society, IARS 2011, Vancouver, BC, Canada. [conference proceedings]">Swaniker 2011</a>). </p> </section> </section> <section id="CD009798-sec-0055"> <h3 class="title">Risk of bias in included studies</h3> <p>We used The Cochrane Collaboration's risk of bias tables to assess the validity and quality of the included trials. The trials showed low or unclear risk of bias primarily because of inadequate information on allocation concealment and other potential sources of bias. For a more detailed description of individual trial qualities, see the table <a href="./references#CD009798-sec-0099" title="">Characteristics of included studies</a>. The various bias domains are presented in the 'Risk of bias graph' and in a 'Risk of bias summary' (<a href="#CD009798-fig-0001">Figure 1</a>; <a href="#CD009798-fig-0002">Figure 2</a>). </p> <section id="CD009798-sec-0056"> <h4 class="title">Allocation</h4> <p>All studies were unclear about allocation concealment. One study (<a href="./references#CD009798-bbs2-0004" title="TsaiCJ , ChuKS , ChenTI , LuDV , WangHM , LuIC . A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation. Anaesthesia2010;65(3):254-9. [MEDLINE: 20105150]">Tsai 2010</a>) was not explicit about how allocation was achieved other than using the phrase "randomly allocated". </p> </section> <section id="CD009798-sec-0057"> <h4 class="title">Blinding</h4> <p>All studies were conducted on a double‐blind basis. One study (<a href="./references#CD009798-bbs2-0002" title="BergeseSD , CandiottiKA , BokeschPM , ZuraA , WisemandleW , BekkerAY . A Phase IIIb, randomized, double-blind, placebo-controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. American Journal of Therapeutics2010;17(6):586-95. [MEDLINE: 20535016]">Bergese 2010b</a>) did not explicitly describe how this was undertaken. We have, however, rated the other three studies as being of higher quality because they stated that the studies were double‐blinded and specifically that either the raters or the participants were blinded. </p> </section> <section id="CD009798-sec-0058"> <h4 class="title">Incomplete outcome data</h4> <p>In all studies, every person who completed the trial was analysed.</p> </section> <section id="CD009798-sec-0059"> <h4 class="title">Selective reporting</h4> <p>The data in this review originated from published papers. We did not have an opportunity to compare outcomes described in the protocol and those reported in the full publications. So we considered selective reporting possible. One study (<a href="./references#CD009798-bbs2-0001" title="BergeseSD , Patrick BenderS , McSweeneyTD , FernandezS , DzwonczykR , SageK . A comparative study of dexmedetomidine with midazolam and midazolam alone for sedation during elective awake fiberoptic intubation. Journal of Clinical Anesthsia2010;22(1):35-40. [MEDLINE: 20206849]">Bergese 2010a</a>) did not provide data on our secondary outcome "Intubation time", and another study (<a href="./references#CD009798-bbs2-0002" title="BergeseSD , CandiottiKA , BokeschPM , ZuraA , WisemandleW , BekkerAY . A Phase IIIb, randomized, double-blind, placebo-controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. American Journal of Therapeutics2010;17(6):586-95. [MEDLINE: 20535016]">Bergese 2010b</a>) did not provide data on our primary outcome "Discomfort during awake fibreoptic intubation" and the secondary outcome "Intubation time". </p> </section> <section id="CD009798-sec-0060"> <h4 class="title">Other potential sources of bias</h4> <p>All studies had small or very small sample sizes. Two studies (<a href="./references#CD009798-bbs2-0001" title="BergeseSD , Patrick BenderS , McSweeneyTD , FernandezS , DzwonczykR , SageK . A comparative study of dexmedetomidine with midazolam and midazolam alone for sedation during elective awake fiberoptic intubation. Journal of Clinical Anesthsia2010;22(1):35-40. [MEDLINE: 20206849]">Bergese 2010a</a>; <a href="./references#CD009798-bbs2-0002" title="BergeseSD , CandiottiKA , BokeschPM , ZuraA , WisemandleW , BekkerAY . A Phase IIIb, randomized, double-blind, placebo-controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. American Journal of Therapeutics2010;17(6):586-95. [MEDLINE: 20535016]">Bergese 2010b</a>) were funded by Hospira, the maker of dexmedetomidine. </p> </section> </section> <section id="CD009798-sec-0061"> <h3 class="title" id="CD009798-sec-0061">Effects of interventions</h3> <p>Owing to clinical heterogeneity and potential methodological heterogeneity, it was impossible to conduct a full meta‐analysis. We described findings from individual studies or presented them in tabular form. </p> <section id="CD009798-sec-0062"> <h4 class="title">Primary outcomes</h4> <section id="CD009798-sec-0063"> <h5 class="title">1, Discomfort during awake fibreoptic intubation (heavy grimacing, verbal objection, defensive movement of head or hand or prolonged cough). </h5> <p>This outcome was reported in three studies involving 125 participants (<a href="./references#CD009798-bbs2-0001" title="BergeseSD , Patrick BenderS , McSweeneyTD , FernandezS , DzwonczykR , SageK . A comparative study of dexmedetomidine with midazolam and midazolam alone for sedation during elective awake fiberoptic intubation. Journal of Clinical Anesthsia2010;22(1):35-40. [MEDLINE: 20206849]">Bergese 2010a</a><a href="./references#CD009798-bbs2-0003" title="ChuKS , WangFY , HsuHT , LuIC , WangHM , TsaiCJ . The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation. European Journal of Anaesthesiology2010;27(1):36-40. [MEDLINE: 19550337]">Chu 2010</a><a href="./references#CD009798-bbs2-0004" title="TsaiCJ , ChuKS , ChenTI , LuDV , WangHM , LuIC . A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation. Anaesthesia2010;65(3):254-9. [MEDLINE: 20105150]">Tsai 2010</a>; <a href="#CD009798-tbl-0003">Table 3</a>). In two studies, participants experienced less discomfort during awake fibreoptic intubation in the dexmedetomidine group than in the control group (<a href="./references#CD009798-bbs2-0001" title="BergeseSD , Patrick BenderS , McSweeneyTD , FernandezS , DzwonczykR , SageK . A comparative study of dexmedetomidine with midazolam and midazolam alone for sedation during elective awake fiberoptic intubation. Journal of Clinical Anesthsia2010;22(1):35-40. [MEDLINE: 20206849]">Bergese 2010a</a>; <a href="./references#CD009798-bbs2-0004" title="TsaiCJ , ChuKS , ChenTI , LuDV , WangHM , LuIC . A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation. Anaesthesia2010;65(3):254-9. [MEDLINE: 20105150]">Tsai 2010</a>). However, in <a href="./references#CD009798-bbs2-0003" title="ChuKS , WangFY , HsuHT , LuIC , WangHM , TsaiCJ . The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation. European Journal of Anaesthesiology2010;27(1):36-40. [MEDLINE: 19550337]">Chu 2010</a>, no significant difference was reported between the dexmedetomidine group and the control group. This outcome was not reported in <a href="./references#CD009798-bbs2-0002" title="BergeseSD , CandiottiKA , BokeschPM , ZuraA , WisemandleW , BekkerAY . A Phase IIIb, randomized, double-blind, placebo-controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. American Journal of Therapeutics2010;17(6):586-95. [MEDLINE: 20535016]">Bergese 2010b</a>. </p> <div class="table" id="CD009798-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Table 1</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Primary outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Discomfort during awake fibreoptic intubation</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009798-bbs2-0001" title="BergeseSD , Patrick BenderS , McSweeneyTD , FernandezS , DzwonczykR , SageK . A comparative study of dexmedetomidine with midazolam and midazolam alone for sedation during elective awake fiberoptic intubation. Journal of Clinical Anesthsia2010;22(1):35-40. [MEDLINE: 20206849]">Bergese 2010a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dexmedetomidine group reacted less (P &lt; 0.001)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009798-bbs2-0002" title="BergeseSD , CandiottiKA , BokeschPM , ZuraA , WisemandleW , BekkerAY . A Phase IIIb, randomized, double-blind, placebo-controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. American Journal of Therapeutics2010;17(6):586-95. [MEDLINE: 20535016]">Bergese 2010b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009798-bbs2-0003" title="ChuKS , WangFY , HsuHT , LuIC , WangHM , TsaiCJ . The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation. European Journal of Anaesthesiology2010;27(1):36-40. [MEDLINE: 19550337]">Chu 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No significant difference between groups</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009798-bbs2-0004" title="TsaiCJ , ChuKS , ChenTI , LuDV , WangHM , LuIC . A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation. Anaesthesia2010;65(3):254-9. [MEDLINE: 20105150]">Tsai 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dexmedetomidine group reacted less (P &lt; 0.05)</p> </td> </tr> </tbody> </table> </div> </section> </section> <section id="CD009798-sec-0064"> <h4 class="title">Secondary outcomes</h4> <section id="CD009798-sec-0065"> <h5 class="title">1. Intubation time.</h5> <p>Only two studies (<a href="./references#CD009798-bbs2-0003" title="ChuKS , WangFY , HsuHT , LuIC , WangHM , TsaiCJ . The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation. European Journal of Anaesthesiology2010;27(1):36-40. [MEDLINE: 19550337]">Chu 2010</a>; <a href="./references#CD009798-bbs2-0004" title="TsaiCJ , ChuKS , ChenTI , LuDV , WangHM , LuIC . A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation. Anaesthesia2010;65(3):254-9. [MEDLINE: 20105150]">Tsai 2010</a>; <a href="#CD009798-tbl-0004">Table 4</a>) involving 70 participants reported on this outcome, both showing no significant difference between the dexmedetomidine group and the control group. </p> <div class="table" id="CD009798-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Table 2</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Secondary outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intubation time</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Airway obstruction</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Hypoxia</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Treatment‐emergent cardiovascular adverse events</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009798-bbs2-0001" title="BergeseSD , Patrick BenderS , McSweeneyTD , FernandezS , DzwonczykR , SageK . A comparative study of dexmedetomidine with midazolam and midazolam alone for sedation during elective awake fiberoptic intubation. Journal of Clinical Anesthsia2010;22(1):35-40. [MEDLINE: 20206849]">Bergese 2010a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clearly reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No significant difference between groups</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No significant difference between groups</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009798-bbs2-0002" title="BergeseSD , CandiottiKA , BokeschPM , ZuraA , WisemandleW , BekkerAY . A Phase IIIb, randomized, double-blind, placebo-controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. American Journal of Therapeutics2010;17(6):586-95. [MEDLINE: 20535016]">Bergese 2010b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clearly reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No significant difference between groups</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No significant difference between groups</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009798-bbs2-0003" title="ChuKS , WangFY , HsuHT , LuIC , WangHM , TsaiCJ . The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation. European Journal of Anaesthesiology2010;27(1):36-40. [MEDLINE: 19550337]">Chu 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No significant difference between groups</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No significant difference between groups</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No significant difference between groups</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No significant difference between groups</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009798-bbs2-0004" title="TsaiCJ , ChuKS , ChenTI , LuDV , WangHM , LuIC . A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation. Anaesthesia2010;65(3):254-9. [MEDLINE: 20105150]">Tsai 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No significant difference between groups</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No significant difference between groups</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No significant difference between groups</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No significant difference between groups</p> </td> </tr> </tbody> </table> </div> </section> <section id="CD009798-sec-0066"> <h5 class="title">2. Airway obstruction (requiring neck extension or jaw retraction).</h5> <p>This outcome was reported clearly in two studies involving 70 participants (<a href="./references#CD009798-bbs2-0003" title="ChuKS , WangFY , HsuHT , LuIC , WangHM , TsaiCJ . The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation. European Journal of Anaesthesiology2010;27(1):36-40. [MEDLINE: 19550337]">Chu 2010</a>; <a href="./references#CD009798-bbs2-0004" title="TsaiCJ , ChuKS , ChenTI , LuDV , WangHM , LuIC . A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation. Anaesthesia2010;65(3):254-9. [MEDLINE: 20105150]">Tsai 2010</a>; <a href="#CD009798-tbl-0004">Table 4</a>). <a href="./references#CD009798-bbs2-0004" title="TsaiCJ , ChuKS , ChenTI , LuDV , WangHM , LuIC . A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation. Anaesthesia2010;65(3):254-9. [MEDLINE: 20105150]">Tsai 2010</a> showed that dexmedetomidine alleviated airway obstruction significantly (P value 0.007), and <a href="./references#CD009798-bbs2-0003" title="ChuKS , WangFY , HsuHT , LuIC , WangHM , TsaiCJ . The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation. European Journal of Anaesthesiology2010;27(1):36-40. [MEDLINE: 19550337]">Chu 2010</a> showed no significant difference between the dexmedetomidine group and the control group. </p> </section> <section id="CD009798-sec-0067"> <h5 class="title">3. Hypoxia (saturated peripheral oxygen (SpO<sub>2</sub>) &lt; 90%). </h5> <p>This outcome was reported in four studies involving 211 participants (<a href="./references#CD009798-bbs2-0001" title="BergeseSD , Patrick BenderS , McSweeneyTD , FernandezS , DzwonczykR , SageK . A comparative study of dexmedetomidine with midazolam and midazolam alone for sedation during elective awake fiberoptic intubation. Journal of Clinical Anesthsia2010;22(1):35-40. [MEDLINE: 20206849]">Bergese 2010a</a>; <a href="./references#CD009798-bbs2-0002" title="BergeseSD , CandiottiKA , BokeschPM , ZuraA , WisemandleW , BekkerAY . A Phase IIIb, randomized, double-blind, placebo-controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. American Journal of Therapeutics2010;17(6):586-95. [MEDLINE: 20535016]">Bergese 2010b</a>; <a href="./references#CD009798-bbs2-0003" title="ChuKS , WangFY , HsuHT , LuIC , WangHM , TsaiCJ . The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation. European Journal of Anaesthesiology2010;27(1):36-40. [MEDLINE: 19550337]">Chu 2010</a>; <a href="./references#CD009798-bbs2-0004" title="TsaiCJ , ChuKS , ChenTI , LuDV , WangHM , LuIC . A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation. Anaesthesia2010;65(3):254-9. [MEDLINE: 20105150]">Tsai 2010</a>; <a href="#CD009798-tbl-0004">Table 4</a>). <a href="./references#CD009798-bbs2-0001" title="BergeseSD , Patrick BenderS , McSweeneyTD , FernandezS , DzwonczykR , SageK . A comparative study of dexmedetomidine with midazolam and midazolam alone for sedation during elective awake fiberoptic intubation. Journal of Clinical Anesthsia2010;22(1):35-40. [MEDLINE: 20206849]">Bergese 2010a</a> reported no complications in either group, and none of the DEX‐MDZ participants experienced respiratory depression. <a href="./references#CD009798-bbs2-0002" title="BergeseSD , CandiottiKA , BokeschPM , ZuraA , WisemandleW , BekkerAY . A Phase IIIb, randomized, double-blind, placebo-controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. American Journal of Therapeutics2010;17(6):586-95. [MEDLINE: 20535016]">Bergese 2010b</a> showed that dexmedetomidine had no significant effect on respiratory function and gas exchange at the doses used in this trial. <a href="./references#CD009798-bbs2-0004" title="TsaiCJ , ChuKS , ChenTI , LuDV , WangHM , LuIC . A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation. Anaesthesia2010;65(3):254-9. [MEDLINE: 20105150]">Tsai 2010</a> showed no significant difference between the dexmedetomidine group and the control group. <a href="./references#CD009798-bbs2-0003" title="ChuKS , WangFY , HsuHT , LuIC , WangHM , TsaiCJ . The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation. European Journal of Anaesthesiology2010;27(1):36-40. [MEDLINE: 19550337]">Chu 2010</a> reported no episode of apnoea or decreased oxygen saturation less than 95% in both groups. </p> </section> <section id="CD009798-sec-0068"> <h5 class="title">4. Treatment‐emergent cardiovascular adverse events, mainly hypotension and bradycardia.</h5> <p>This outcome was reported in four studies involving 211 participants (<a href="./references#CD009798-bbs2-0001" title="BergeseSD , Patrick BenderS , McSweeneyTD , FernandezS , DzwonczykR , SageK . A comparative study of dexmedetomidine with midazolam and midazolam alone for sedation during elective awake fiberoptic intubation. Journal of Clinical Anesthsia2010;22(1):35-40. [MEDLINE: 20206849]">Bergese 2010a</a>; <a href="./references#CD009798-bbs2-0002" title="BergeseSD , CandiottiKA , BokeschPM , ZuraA , WisemandleW , BekkerAY . A Phase IIIb, randomized, double-blind, placebo-controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. American Journal of Therapeutics2010;17(6):586-95. [MEDLINE: 20535016]">Bergese 2010b</a>; <a href="./references#CD009798-bbs2-0003" title="ChuKS , WangFY , HsuHT , LuIC , WangHM , TsaiCJ . The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation. European Journal of Anaesthesiology2010;27(1):36-40. [MEDLINE: 19550337]">Chu 2010</a>; <a href="./references#CD009798-bbs2-0004" title="TsaiCJ , ChuKS , ChenTI , LuDV , WangHM , LuIC . A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation. Anaesthesia2010;65(3):254-9. [MEDLINE: 20105150]">Tsai 2010</a>; <a href="#CD009798-tbl-0004">Table 4</a>). <a href="./references#CD009798-bbs2-0001" title="BergeseSD , Patrick BenderS , McSweeneyTD , FernandezS , DzwonczykR , SageK . A comparative study of dexmedetomidine with midazolam and midazolam alone for sedation during elective awake fiberoptic intubation. Journal of Clinical Anesthsia2010;22(1):35-40. [MEDLINE: 20206849]">Bergese 2010a</a> showed no significant haemodynamic difference between the two subject groups. <a href="./references#CD009798-bbs2-0002" title="BergeseSD , CandiottiKA , BokeschPM , ZuraA , WisemandleW , BekkerAY . A Phase IIIb, randomized, double-blind, placebo-controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. American Journal of Therapeutics2010;17(6):586-95. [MEDLINE: 20535016]">Bergese 2010b</a> reported that seven dexmedetomidine‐treated participants and four placebo‐treated participants received an intravenous fluid bolus or medication to treat blood pressure or heart rate (HR) during study drug infusion. The difference was insignificant. Both <a href="./references#CD009798-bbs2-0004" title="TsaiCJ , ChuKS , ChenTI , LuDV , WangHM , LuIC . A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation. Anaesthesia2010;65(3):254-9. [MEDLINE: 20105150]">Tsai 2010</a> and <a href="./references#CD009798-bbs2-0003" title="ChuKS , WangFY , HsuHT , LuIC , WangHM , TsaiCJ . The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation. European Journal of Anaesthesiology2010;27(1):36-40. [MEDLINE: 19550337]">Chu 2010</a> showed that haemodynamic support did not differ significantly between the dexmedetomidine group and the control group. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD009798-sec-0069" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD009798-sec-0069"></div> <section id="CD009798-sec-0070"> <h3 class="title" id="CD009798-sec-0070">Summary of main results</h3> <p>The research on dexmedetomidine for the management of awake fibreoptic intubation has started only within the past few years, so in this review, only four studies involving 211 participants were included (<a href="./references#CD009798-bbs2-0001" title="BergeseSD , Patrick BenderS , McSweeneyTD , FernandezS , DzwonczykR , SageK . A comparative study of dexmedetomidine with midazolam and midazolam alone for sedation during elective awake fiberoptic intubation. Journal of Clinical Anesthsia2010;22(1):35-40. [MEDLINE: 20206849]">Bergese 2010a</a>; <a href="./references#CD009798-bbs2-0002" title="BergeseSD , CandiottiKA , BokeschPM , ZuraA , WisemandleW , BekkerAY . A Phase IIIb, randomized, double-blind, placebo-controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. American Journal of Therapeutics2010;17(6):586-95. [MEDLINE: 20535016]">Bergese 2010b</a>; <a href="./references#CD009798-bbs2-0003" title="ChuKS , WangFY , HsuHT , LuIC , WangHM , TsaiCJ . The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation. European Journal of Anaesthesiology2010;27(1):36-40. [MEDLINE: 19550337]">Chu 2010</a>; <a href="./references#CD009798-bbs2-0004" title="TsaiCJ , ChuKS , ChenTI , LuDV , WangHM , LuIC . A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation. Anaesthesia2010;65(3):254-9. [MEDLINE: 20105150]">Tsai 2010</a>). It is true that some outcomes of interest for this review were not reported in these studies. The analytic results were derived from sparse data. </p> <p>Dexmedetomidine‐treated participants reacted less than control‐treated participants to awake fibreoptic intubation in two trials (<a href="./references#CD009798-bbs2-0001" title="BergeseSD , Patrick BenderS , McSweeneyTD , FernandezS , DzwonczykR , SageK . A comparative study of dexmedetomidine with midazolam and midazolam alone for sedation during elective awake fiberoptic intubation. Journal of Clinical Anesthsia2010;22(1):35-40. [MEDLINE: 20206849]">Bergese 2010a</a>; <a href="./references#CD009798-bbs2-0004" title="TsaiCJ , ChuKS , ChenTI , LuDV , WangHM , LuIC . A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation. Anaesthesia2010;65(3):254-9. [MEDLINE: 20105150]">Tsai 2010</a>). The decreased discomfort achieved with dexmedetomidine favours maintaining patient co‐operation and reducing anxiety during AFOI and could play an important role in securing the airway of patients with an unstable cervical spine or a compromised spinal cord. </p> <p>No suggestion indicates that dexmedetomidine had a greater effect on intubation time than was seen with the control. Dexmedetomidine does not predispose to airway obstruction and respiratory depression. Airway obstruction occurred more frequently in the propofol group than in the dexmedetomidine group. The incidence of hypoxia was similar between the dexmedetomidine group and the control group and was clinically insignificant. Treatment‐emergent cardiovascular adverse events, mainly hypotension and bradycardia, were reported in some studies for the dexmedetomidine group and for the control group as well. Most adverse effects were mild or moderate in severity and could be easily managed with atropine, ephedrine and intravenous fluid administration. The results of this review do not suggest that dexmedetomidine causes significantly more cardiovascular adverse events. </p> </section> <section id="CD009798-sec-0071"> <h3 class="title" id="CD009798-sec-0071">Overall completeness and applicability of evidence</h3> <p>No outcomes in this review involved large numbers of participants. The primary outcome "Discomfort during awake fibreoptic intubation" was not reported in one study (<a href="./references#CD009798-bbs2-0002" title="BergeseSD , CandiottiKA , BokeschPM , ZuraA , WisemandleW , BekkerAY . A Phase IIIb, randomized, double-blind, placebo-controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. American Journal of Therapeutics2010;17(6):586-95. [MEDLINE: 20535016]">Bergese 2010b</a>). All studies were performed in hospital settings, and all included participants were anticipated to have a difficult or unstable airway. The intervention dexmedetomidine is readily accessible, and the outcomes are objective in terms of clinical practice. Dexmedetomidine had important effects, so the findings might well be applicable. </p> </section> <section id="CD009798-sec-0072"> <h3 class="title" id="CD009798-sec-0072">Quality of the evidence</h3> <p>The largest study in this area (<a href="./references#CD009798-bbs2-0002" title="BergeseSD , CandiottiKA , BokeschPM , ZuraA , WisemandleW , BekkerAY . A Phase IIIb, randomized, double-blind, placebo-controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. American Journal of Therapeutics2010;17(6):586-95. [MEDLINE: 20535016]">Bergese 2010b</a>) was a multicentre (17 medical centres) study that included 86 participants between August 7, 2006, and January 26, 2007. It is impossible to detect subtle yet important differences due to dexmedetomidine with any confidence. Although the four studies are all RCTs without high risk of bias, the overall quality of reporting of these studies was very low because allocation concealment was not described and other bias could not be excluded. In addition, the small study size and the poor reporting of studies would be associated with an exaggeration of effect of the experimental treatment if an effect had been detected (<a href="./references#CD009798-bbs2-0021" title="JuniP , AltmanD , EggerM . Systematic reviews in health care:assessing the quality of controlled clinical trials. BMJ2001;323(7303):42-6. [MEDLINE: 11440947 ]">Juni 2001</a>). Comparisons were performed between dexmedetomidine and any control (including sodium chloride, fentanyl, midazolam and propofol) in the four different studies included in this review. In consideration of the clinical heterogeneity and the likely methodological heterogeneity (measurement of outcomes) that might cause a negative influence in the quality of evidence, we did not perform a full meta‐analysis instead of a narrative analysis (<a href="#CD009798-tbl-0005">Table 5</a>). </p> <div class="table" id="CD009798-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Results of included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Interventions</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcomes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Main results</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009798-bbs2-0001" title="BergeseSD , Patrick BenderS , McSweeneyTD , FernandezS , DzwonczykR , SageK . A comparative study of dexmedetomidine with midazolam and midazolam alone for sedation during elective awake fiberoptic intubation. Journal of Clinical Anesthsia2010;22(1):35-40. [MEDLINE: 20206849]">Bergese 2010a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MDZ group (n = 24): Participants received IV midazolam 0.05 mg/kg with additional doses to achieve a Ramsay Sedation Scale (RSS) score ≥ two </p> <p>DEX‐MDZ group (n = 31): Participants received midazolam 0.02 mg/kg followed by dexmedetomidine 1 μg/kg, then an infusion of dexmedetomidine 0.1 μg/kg/h and titrated to 0.7 μg/kg/h to achieve RSS ≥ two </p> <p>Topical local anaesthetics were given</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Discomfort during awake fibreoptic intubation (Participants were assessed on a scale of one to five: one: no reaction; two: slight grimacing; three: severe grimacing; four: verbal objection; five: defensive movement of head, hands or feet) </p> <p>Airway obstruction (no details)</p> <p>Hypoxia (no details)</p> <p>Treatment‐emergent cardiovascular adverse events (no details)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DEX‐MDZ participants reacted less to AFOI than did MDZ participants (P &lt; 0.01)</p> <p>No complications were reported in either participant group, and none of the 31 DEX‐MDZ participants experienced respiratory depression </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009798-bbs2-0002" title="BergeseSD , CandiottiKA , BokeschPM , ZuraA , WisemandleW , BekkerAY . A Phase IIIb, randomized, double-blind, placebo-controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. American Journal of Therapeutics2010;17(6):586-95. [MEDLINE: 20535016]">Bergese 2010b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dexmedetomidine (n = 47): Participants received a loading dose of 1.0 mcg/kg over 10 minutes, followed by a continuous infusion of 0.7 mcg/kg<sup>‐1</sup>/h<sup>‐1</sup>. The study drug was started 15 minutes before airway topicalization for AFOI </p> <p>Placebo group (n = 39): Participants received a loading dose and a maintenance infusion of 0.9% sodium chloride for injection at a volume and rate equal to that of dexmedetomidine. Fifteen minutes after the start of the study drug infusion and before airway topicalization, any participant with Ramsay Sedation Scale &lt; two received rescue midazolam to achieve targeted sedation (RSS &gt;= two) before topicalization and throughout AFOI </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Airway obstruction</p> <p>Hypoxia (no details)</p> <p>Treatment‐emergent cardiovascular adverse events (no details)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dexmedetomidine has no significant effect on respiratory function and gas exchange at the doses used in this trial. Dexmedetomidine is well tolerated and does not compromise the airway </p> <p>Seven dexmedetomidine‐treated participants (12.7%) and four placebo‐treated participants (8.0%) received intravenous fluid bolus or medication to treat blood pressure or HR during study drug infusion </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009798-bbs2-0003" title="ChuKS , WangFY , HsuHT , LuIC , WangHM , TsaiCJ . The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation. European Journal of Anaesthesiology2010;27(1):36-40. [MEDLINE: 19550337]">Chu 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dex group (n = 16): Participants received dexmedetomidine (1.0 μg/kg‐1) infusion</p> <p>Control group (n = 14): Participants received fentanyl (1.0 μg/kg‐1) infusion</p> <p>Topical anaesthesia was performed after the middle of infusion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Discomfort during awake fibreoptic intubation (Participants were assessed on a scale of one to five: one: no movement; two: grimacing; three: mild cough; four: major limb movement; five: prolonged cough) </p> <p>Intubation time (from insertion of fibreoptic scope to confirmation of nasal tracheal intubation) </p> <p>Airway obstruction (Participants were assessed on a scale of one to three: one: patent airway; two: airway obstruction relieved by neck extension; three: airway obstruction requiring jaw retraction) </p> <p>Hypoxia (SpO<sub>2</sub> &lt; 94%) </p> <p>Treatment‐emergent cardiovascular adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No differences between the two groups were noted for discomfort during awake fibreoptic intubation, intubation time, airway obstruction, hypoxia or treatment‐emergent cardiovascular adverse events </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009798-bbs2-0004" title="TsaiCJ , ChuKS , ChenTI , LuDV , WangHM , LuIC . A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation. Anaesthesia2010;65(3):254-9. [MEDLINE: 20105150]">Tsai 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dexmedetomidine group (n = 20): Participants received a loading dose of dexmedetomidine (1.0 μg/kg‐1) infused over 10 minutes </p> <p>Propofol group (n = 20): Participants received propofol. The initial target effect site concentration (Ce) was set at 3 μg/mL<sup>‐1</sup>. This was adjusted by 1.0 μg/mL<sup>‐1</sup> according to participant comfort during the procedure. If a comfort score exceeded three or a persistent cough occurred during the procedure, the TCI was titrated upwards, after which the intubating anaesthetist waited for 60 seconds before proceeding. While waiting for the desired level of sedation to be achieved, topical anaesthesia was applied to the airway </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Discomfort during awake fibreoptic intubation (Participants were assessed on a scale of one to five: one: no reaction; two: slight grimacing; three: heavy grimacing; four: verbal objection; five: defensive movement of head or hands) </p> <p>Intubation time (time taken from insertion of the fibreoptic scope to confirmation of nasotracheal intubation) </p> <p>Airway obstruction (Participants were assessed on a scale of one to three: one: patent airway; two: airway obstruction relieved by neck extension; three: airway obstruction requiring jaw retraction) </p> <p>Hypoxia (no details)</p> <p>Treatment‐emergent cardiovascular adverse events (no details)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DEX participants reacted less to AFOI than did the propofol participants (P &lt; 0.01)</p> <p>No differences between the two groups were noted for intubation time or hypoxia</p> <p>The dexmedetomidine group experienced fewer airway events and less heart rate response than did the propofol group (P &lt; 0.003 and P value 0.007,respectively) </p> </td> </tr> </tbody> </table> </div> </section> <section id="CD009798-sec-0073"> <h3 class="title" id="CD009798-sec-0073">Potential biases in the review process</h3> <section id="CD009798-sec-0074"> <h4 class="title">1. Missing studies.</h4> <p>Although we have tried our best to identify all relevant studies, it is possible that some small studies are missing from this review. However, because of the comprehensive searching strategy provided by Karen Hovhannisyan (Cochrane Anaesthesia Review Group Trials Search Co‐ordinator), we are confident that we have not failed to identify large relevant studies. </p> </section> </section> <section id="CD009798-sec-0075"> <h3 class="title" id="CD009798-sec-0075">Agreements and disagreements with other studies or reviews</h3> <p>No previous Cochrane review or relevant systemic review was performed.</p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD009798-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009798.pub2/media/CDSR/CD009798/urn:x-wiley:14651858:media:CD009798:CD009798-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD009798-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009798.pub2/media/CDSR/CD009798/image_n/nCD009798-FIG-01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009798.pub2/media/CDSR/CD009798/image_t/tCD009798-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009798.pub2/full#CD009798-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009798.pub2/media/CDSR/CD009798/image_n/nCD009798-FIG-01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009798-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009798.pub2/media/CDSR/CD009798/urn:x-wiley:14651858:media:CD009798:CD009798-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study." data-id="CD009798-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009798.pub2/media/CDSR/CD009798/image_n/nCD009798-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009798.pub2/media/CDSR/CD009798/image_t/tCD009798-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009798.pub2/full#CD009798-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009798.pub2/media/CDSR/CD009798/image_n/nCD009798-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009798-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009798.pub2/media/CDSR/CD009798/urn:x-wiley:14651858:media:CD009798:CD009798-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD009798-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009798.pub2/media/CDSR/CD009798/image_n/nCD009798-FIG-03.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009798.pub2/media/CDSR/CD009798/image_t/tCD009798-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009798.pub2/full#CD009798-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009798.pub2/media/CDSR/CD009798/image_n/nCD009798-FIG-03.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD009798-tbl-0001"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Raw data for Chu 2010</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FOI comfort (1, 2, 3, 4, 5)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Dexmedetomidine</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Fentanyl</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Raw data for Chu 2010</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009798.pub2/full#CD009798-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009798-tbl-0002"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Raw data for Tsai 2010</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FOI comfort (1, 2, 3, 4, 5)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Dexmedetomidine</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Propofo</b>l </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Raw data for Tsai 2010</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009798.pub2/full#CD009798-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009798-tbl-0003"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Table 1</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Primary outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Discomfort during awake fibreoptic intubation</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009798-bbs2-0001" title="BergeseSD , Patrick BenderS , McSweeneyTD , FernandezS , DzwonczykR , SageK . A comparative study of dexmedetomidine with midazolam and midazolam alone for sedation during elective awake fiberoptic intubation. Journal of Clinical Anesthsia2010;22(1):35-40. [MEDLINE: 20206849]">Bergese 2010a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dexmedetomidine group reacted less (P &lt; 0.001)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009798-bbs2-0002" title="BergeseSD , CandiottiKA , BokeschPM , ZuraA , WisemandleW , BekkerAY . A Phase IIIb, randomized, double-blind, placebo-controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. American Journal of Therapeutics2010;17(6):586-95. [MEDLINE: 20535016]">Bergese 2010b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009798-bbs2-0003" title="ChuKS , WangFY , HsuHT , LuIC , WangHM , TsaiCJ . The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation. European Journal of Anaesthesiology2010;27(1):36-40. [MEDLINE: 19550337]">Chu 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No significant difference between groups</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009798-bbs2-0004" title="TsaiCJ , ChuKS , ChenTI , LuDV , WangHM , LuIC . A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation. Anaesthesia2010;65(3):254-9. [MEDLINE: 20105150]">Tsai 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dexmedetomidine group reacted less (P &lt; 0.05)</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Table 1</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009798.pub2/full#CD009798-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009798-tbl-0004"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Table 2</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Secondary outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intubation time</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Airway obstruction</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Hypoxia</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Treatment‐emergent cardiovascular adverse events</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009798-bbs2-0001" title="BergeseSD , Patrick BenderS , McSweeneyTD , FernandezS , DzwonczykR , SageK . A comparative study of dexmedetomidine with midazolam and midazolam alone for sedation during elective awake fiberoptic intubation. Journal of Clinical Anesthsia2010;22(1):35-40. [MEDLINE: 20206849]">Bergese 2010a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clearly reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No significant difference between groups</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No significant difference between groups</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009798-bbs2-0002" title="BergeseSD , CandiottiKA , BokeschPM , ZuraA , WisemandleW , BekkerAY . A Phase IIIb, randomized, double-blind, placebo-controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. American Journal of Therapeutics2010;17(6):586-95. [MEDLINE: 20535016]">Bergese 2010b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clearly reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No significant difference between groups</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No significant difference between groups</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009798-bbs2-0003" title="ChuKS , WangFY , HsuHT , LuIC , WangHM , TsaiCJ . The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation. European Journal of Anaesthesiology2010;27(1):36-40. [MEDLINE: 19550337]">Chu 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No significant difference between groups</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No significant difference between groups</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No significant difference between groups</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No significant difference between groups</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009798-bbs2-0004" title="TsaiCJ , ChuKS , ChenTI , LuDV , WangHM , LuIC . A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation. Anaesthesia2010;65(3):254-9. [MEDLINE: 20105150]">Tsai 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No significant difference between groups</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No significant difference between groups</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No significant difference between groups</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No significant difference between groups</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Table 2</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009798.pub2/full#CD009798-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009798-tbl-0005"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Results of included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Interventions</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcomes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Main results</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009798-bbs2-0001" title="BergeseSD , Patrick BenderS , McSweeneyTD , FernandezS , DzwonczykR , SageK . A comparative study of dexmedetomidine with midazolam and midazolam alone for sedation during elective awake fiberoptic intubation. Journal of Clinical Anesthsia2010;22(1):35-40. [MEDLINE: 20206849]">Bergese 2010a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MDZ group (n = 24): Participants received IV midazolam 0.05 mg/kg with additional doses to achieve a Ramsay Sedation Scale (RSS) score ≥ two </p> <p>DEX‐MDZ group (n = 31): Participants received midazolam 0.02 mg/kg followed by dexmedetomidine 1 μg/kg, then an infusion of dexmedetomidine 0.1 μg/kg/h and titrated to 0.7 μg/kg/h to achieve RSS ≥ two </p> <p>Topical local anaesthetics were given</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Discomfort during awake fibreoptic intubation (Participants were assessed on a scale of one to five: one: no reaction; two: slight grimacing; three: severe grimacing; four: verbal objection; five: defensive movement of head, hands or feet) </p> <p>Airway obstruction (no details)</p> <p>Hypoxia (no details)</p> <p>Treatment‐emergent cardiovascular adverse events (no details)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DEX‐MDZ participants reacted less to AFOI than did MDZ participants (P &lt; 0.01)</p> <p>No complications were reported in either participant group, and none of the 31 DEX‐MDZ participants experienced respiratory depression </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009798-bbs2-0002" title="BergeseSD , CandiottiKA , BokeschPM , ZuraA , WisemandleW , BekkerAY . A Phase IIIb, randomized, double-blind, placebo-controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. American Journal of Therapeutics2010;17(6):586-95. [MEDLINE: 20535016]">Bergese 2010b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dexmedetomidine (n = 47): Participants received a loading dose of 1.0 mcg/kg over 10 minutes, followed by a continuous infusion of 0.7 mcg/kg<sup>‐1</sup>/h<sup>‐1</sup>. The study drug was started 15 minutes before airway topicalization for AFOI </p> <p>Placebo group (n = 39): Participants received a loading dose and a maintenance infusion of 0.9% sodium chloride for injection at a volume and rate equal to that of dexmedetomidine. Fifteen minutes after the start of the study drug infusion and before airway topicalization, any participant with Ramsay Sedation Scale &lt; two received rescue midazolam to achieve targeted sedation (RSS &gt;= two) before topicalization and throughout AFOI </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Airway obstruction</p> <p>Hypoxia (no details)</p> <p>Treatment‐emergent cardiovascular adverse events (no details)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dexmedetomidine has no significant effect on respiratory function and gas exchange at the doses used in this trial. Dexmedetomidine is well tolerated and does not compromise the airway </p> <p>Seven dexmedetomidine‐treated participants (12.7%) and four placebo‐treated participants (8.0%) received intravenous fluid bolus or medication to treat blood pressure or HR during study drug infusion </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009798-bbs2-0003" title="ChuKS , WangFY , HsuHT , LuIC , WangHM , TsaiCJ . The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation. European Journal of Anaesthesiology2010;27(1):36-40. [MEDLINE: 19550337]">Chu 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dex group (n = 16): Participants received dexmedetomidine (1.0 μg/kg‐1) infusion</p> <p>Control group (n = 14): Participants received fentanyl (1.0 μg/kg‐1) infusion</p> <p>Topical anaesthesia was performed after the middle of infusion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Discomfort during awake fibreoptic intubation (Participants were assessed on a scale of one to five: one: no movement; two: grimacing; three: mild cough; four: major limb movement; five: prolonged cough) </p> <p>Intubation time (from insertion of fibreoptic scope to confirmation of nasal tracheal intubation) </p> <p>Airway obstruction (Participants were assessed on a scale of one to three: one: patent airway; two: airway obstruction relieved by neck extension; three: airway obstruction requiring jaw retraction) </p> <p>Hypoxia (SpO<sub>2</sub> &lt; 94%) </p> <p>Treatment‐emergent cardiovascular adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No differences between the two groups were noted for discomfort during awake fibreoptic intubation, intubation time, airway obstruction, hypoxia or treatment‐emergent cardiovascular adverse events </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009798-bbs2-0004" title="TsaiCJ , ChuKS , ChenTI , LuDV , WangHM , LuIC . A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation. Anaesthesia2010;65(3):254-9. [MEDLINE: 20105150]">Tsai 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dexmedetomidine group (n = 20): Participants received a loading dose of dexmedetomidine (1.0 μg/kg‐1) infused over 10 minutes </p> <p>Propofol group (n = 20): Participants received propofol. The initial target effect site concentration (Ce) was set at 3 μg/mL<sup>‐1</sup>. This was adjusted by 1.0 μg/mL<sup>‐1</sup> according to participant comfort during the procedure. If a comfort score exceeded three or a persistent cough occurred during the procedure, the TCI was titrated upwards, after which the intubating anaesthetist waited for 60 seconds before proceeding. While waiting for the desired level of sedation to be achieved, topical anaesthesia was applied to the airway </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Discomfort during awake fibreoptic intubation (Participants were assessed on a scale of one to five: one: no reaction; two: slight grimacing; three: heavy grimacing; four: verbal objection; five: defensive movement of head or hands) </p> <p>Intubation time (time taken from insertion of the fibreoptic scope to confirmation of nasotracheal intubation) </p> <p>Airway obstruction (Participants were assessed on a scale of one to three: one: patent airway; two: airway obstruction relieved by neck extension; three: airway obstruction requiring jaw retraction) </p> <p>Hypoxia (no details)</p> <p>Treatment‐emergent cardiovascular adverse events (no details)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DEX participants reacted less to AFOI than did the propofol participants (P &lt; 0.01)</p> <p>No differences between the two groups were noted for intubation time or hypoxia</p> <p>The dexmedetomidine group experienced fewer airway events and less heart rate response than did the propofol group (P &lt; 0.003 and P value 0.007,respectively) </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Results of included studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009798.pub2/full#CD009798-tbl-0005">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD009798.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD009798-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD009798-note-0002">فارسی</a> </li> <li class="section-language"> <a class="" href="ms#CD009798-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD009798-note-0001">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br/> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009798\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009798\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009798\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009798\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009798\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009798\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009798\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009798\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009798\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009798\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009798\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009798\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009798\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009798\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009798\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009798\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009798\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009798\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=ZCrlluee&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009798.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009798.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD009798.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD009798.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009798.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727981653"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009798.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727981657"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009798.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918eb957d85f937f',t:'MTc0MDcyNzk4MS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 